(PRESS RELEASE) MUNICH, 09-Jan-2019 — /EuropaWire/ — Defects in the geneTREM2 are linked to increased risk of Alzheimer’s disease. The gene…
MUNICH, 14-Aug-2018 — /EuropaWire/ — Effective therapeutics to counteract the formation of amyloid plaques in Alzheimer's disease and type 2 diabetes…
First of its kind Printed Memories portal designed to bring families closer together LONDON, 13-Jun-2018 — /EuropaWire/ — Ricoh has launched…
Body-worn sensors used at home and in clinic by people with mild Alzheimer’s to assess walking could offer a cost-effective…
People with Alzheimer’s disease are helping with a ground-breaking government-funded trial but with new sites recently opened in the South…
Agglutinated proteins in the brain, known as amyloid-β plaques, are a key characteristic of Alzheimer’s. One treatment option uses special…
Brussels, 1-5-2013 — /europawire.eu/ — At the start of its 'European Month of the Brain' initiative, the European Commission has earmarked some €150 million…